• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个患有多外显子缺失的家族中的无症状性贝克尔肌肉营养不良症。

Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion.

作者信息

Ferreiro Verónica, Giliberto Florencia, Muñiz García M Noelia, Francipane Liliana, Marzese Diego M, Mampel Alejandra, Roqué María, Frechtel Gustavo D, Szijan Irene

机构信息

Genetics Division, Clinical Hospital "José de San Martín," University of Buenos Aires, 2250 Paraguay, 1120 Buenos Aires, Argentina.

出版信息

Muscle Nerve. 2009 Feb;39(2):239-43. doi: 10.1002/mus.21193.

DOI:10.1002/mus.21193
PMID:19012301
Abstract

We report a Becker muscular dystrophy (BMD) family with one 5-year-old affected patient and a 69-year-old asymptomatic grandfather. Dystrophin gene multiplex polymerase chain reaction and multiplex ligation-dependant probe amplification analysis showed that both males carried an in-frame deletion of exons 45-55. Segregation analysis revealed two additional asymptomatic boys in this family. Our finding supports previous predictions that exons 45-55 are the optimal multiexon skipping target in antisense gene therapy to transform the severe Duchenne muscular dystrophy into the milder BMD, or even asymptomatic, phenotype.

摘要

我们报告了一个贝克型肌营养不良(BMD)家族,其中有一名5岁的患病患者和一位69岁无症状的祖父。肌营养不良蛋白基因多重聚合酶链反应和多重连接依赖探针扩增分析表明,两名男性均携带45-55号外显子的框内缺失。家系分析显示该家族还有另外两名无症状男孩。我们的发现支持了之前的预测,即45-55号外显子是反义基因治疗中将严重的杜氏肌营养不良转化为较轻的BMD甚至无症状表型的最佳多外显子跳跃靶点。

相似文献

1
Asymptomatic Becker muscular dystrophy in a family with a multiexon deletion.一个患有多外显子缺失的家族中的无症状性贝克尔肌肉营养不良症。
Muscle Nerve. 2009 Feb;39(2):239-43. doi: 10.1002/mus.21193.
2
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.多外显子跳跃导致产生一种缺失外显子45至55氨基酸的人工杜兴肌营养不良蛋白,这可以挽救高达63%的杜兴肌营养不良患者。
Hum Mutat. 2007 Feb;28(2):196-202. doi: 10.1002/humu.20428.
3
[Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].[联合多重PCR和MLPA方法检测杜氏肌营养不良症患者、携带者及产前诊断中的缺失和重复]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Jun;26(3):318-22. doi: 10.3760/cma.j.issn.1003-9406.2009.03.018.
4
Becker muscular dystrophy with r(X) carrying an out-of-frame DMD deletion.携带框外DMD缺失的r(X)型贝克肌营养不良症。
Pediatr Neurol. 2008 Aug;39(2):129-32. doi: 10.1016/j.pediatrneurol.2008.05.002.
5
Genetic diagnosis of Duchenne and Becker muscular dystrophy using multiplex ligation-dependent probe amplification in Rwandan patients.使用多重连接依赖性探针扩增技术对卢旺达患者进行 Duchenne 和 Becker 肌营养不良症的基因诊断。
J Trop Pediatr. 2014 Apr;60(2):112-7. doi: 10.1093/tropej/fmt090. Epub 2013 Nov 7.
6
Characterization of deletion breakpoints in patients with dystrophinopathy carrying a deletion of exons 45-55 of the Duchenne muscular dystrophy (DMD) gene.对携带 Duchenne 肌营养不良症 (DMD) 基因外显子 45-55 缺失的肌营养不良症患者的缺失断点进行特征分析。
J Hum Genet. 2009 Feb;54(2):127-30. doi: 10.1038/jhg.2008.8. Epub 2009 Jan 9.
7
Molecular deletion patterns in Duchenne and Becker muscular dystrophy patients from KwaZulu Natal.夸祖鲁-纳塔尔省杜兴氏和贝克氏肌肉营养不良症患者的分子缺失模式
J Neurol Sci. 2007 Jan 15;252(1):1-3. doi: 10.1016/j.jns.2006.06.025. Epub 2006 Dec 1.
8
Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis.杜兴氏和贝克氏肌营养不良症患者中肌营养不良蛋白基因的缺失分析:在携带者诊断中的应用
Neurol India. 2003 Jun;51(2):223-6.
9
Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families - detection of carrier status in symptomatic and asymptomatic female relatives.匈牙利杜兴氏/贝克氏肌营养不良症家族中的肌营养不良蛋白基因分析——有症状和无症状女性亲属携带者状态的检测
Neuromuscul Disord. 2009 Feb;19(2):108-12. doi: 10.1016/j.nmd.2008.10.011. Epub 2008 Dec 11.
10
Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.沙特杜兴氏和贝克氏肌营养不良症患者肌营养不良蛋白基因的缺失突变
Saudi Med J. 2002 Dec;23(12):1478-82.

引用本文的文献

1
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects.腺相关病毒微小肌营养不良蛋白基因替代疗法治疗杜氏肌营养不良症:进展与前景
Gene Ther. 2025 Aug 15. doi: 10.1038/s41434-025-00561-6.
2
An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database.基于 UMD-DMD 数据库的杜氏肌营养不良症外显子跳跃适用性的更新分析。
Genes (Basel). 2024 Nov 20;15(11):1489. doi: 10.3390/genes15111489.
3
Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model.
杜兴肌营养不良症(DMD)基因中外显子45至55的缺失:从治疗角度到体外模型
Skelet Muscle. 2024 Oct 1;14(1):21. doi: 10.1186/s13395-024-00353-3.
4
The complex landscape of DMD mutations: moving towards personalized medicine.杜氏肌营养不良症(DMD)突变的复杂情况:迈向个性化医疗
Front Genet. 2024 Mar 26;15:1360224. doi: 10.3389/fgene.2024.1360224. eCollection 2024.
5
deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis.轻度肌营养不良症相关缺失:文献综述突出了与表型相关的突变簇,并提供了有关遗传机制和预后的见解。
Front Neurol. 2024 Jan 15;14:1288721. doi: 10.3389/fneur.2023.1288721. eCollection 2023.
6
Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1.外显子跳跃疗法对肌动蛋白结合结构域1发生突变的杜氏肌营养不良症心肌病的疗效。
Mol Ther Nucleic Acids. 2023 Oct 19;34:102060. doi: 10.1016/j.omtn.2023.102060. eCollection 2023 Dec 12.
7
Advances in Dystrophinopathy Diagnosis and Therapy.肌营养不良症的诊断和治疗进展。
Biomolecules. 2023 Aug 28;13(9):1319. doi: 10.3390/biom13091319.
8
Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs.双重 CRISPR-Cas3 系统诱导 DMD 患者来源 iPSCs 中外显子跳跃。
Stem Cell Reports. 2023 Sep 12;18(9):1753-1765. doi: 10.1016/j.stemcr.2023.07.007. Epub 2023 Aug 24.
9
CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives.基于 CRISPR 的杜氏肌营养不良症治疗性基因编辑:进展、挑战与展望。
Cells. 2022 Sep 22;11(19):2964. doi: 10.3390/cells11192964.
10
CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies.CRISPR 在杜氏肌营养不良症中的应用:从动物模型到潜在疗法。
WIREs Mech Dis. 2023 Jan;15(1):e1580. doi: 10.1002/wsbm.1580. Epub 2022 Jul 31.